Thus, an increase in the population of myPafs expressing α-SMA before the onset of PDAC is a factor associated with a worse prognosis in patients with PDAC complicated with T2D in combination with epigenetic changes in PDAC cells. The gene discussed is ACTA1; the disease is type 2 diabetes mellitus.